ก.ค. 14, 2563 by Philips
Reading time: 1-2 minutes

Ostial and bifurcation lesions

Ostial and bifurcation lesions represent nearly 40% of complex PCI’s.¹

Clinical challenges

Ostial and bifurcation lesions are associated with higher rates of adverse cardiac events.^2,3
Angiographic details of ostial and bifurcation lesions are often obscured due to angulation and overlap.
Identifying the proper treatment strategy is difficult with traditional angiography.Risk of plaque or carina shift could cut off blood supply

89% reduction in all-cause mortality at 4 years.⁴

Philips IVUS and SyncVision advanced imaging solution:

Study data reported IVUS guidance was associated with an 89% reduction in all-cause mortality in bifurcation lesions and 50% reduction in the compsite of cardiovascular death, MI, or TLR in ostial lesions.²
Assist in identifying the true ostium, plaque distribution, vessel sizez and lesion length.
Aid in therapy delivery by avoiding geographic miss or extending stent struts into the ostium.Co-registration allows you to more easily coorelate plaque and treatment locations to the angiogram.

AngioSculpt PTCA scoring balloon catheter:

Helps you apply maximum dilation force with less risk of dissection compared to other PTCA balloons.⁶
Avoids slippage during dilation by locking in place with its unique rectangular nitinol scoring elements.
Associated with excellent and safe procedural results, a low rate of crossover to side-branch stenting, and favorable outcomes for the treatment of true bifurcation lesions.

Go to register to Radcliffe Cardiology and download the Bifurcation Whitepaper

Share this article

Contact sales

Sign up to receive news and updates from Philips

Sign up

Explore more

เราให้ความสำคัญกับสิ่งที่คุณต้องการ

เพียงบอกเราในสิ่งที่คุณต้องการให้ช่วย

1

เลือกหัวข้อที่สนใจ

ติดต่อ
ความช่วยเหลือ

ต้องการความช่วยเหลือด้านเทคนิค เกี่ยวกับผลิตภัณฑ์เฮลท์แคร์ Technical support

ต้องการเอกสารและคู่มือการใช้งาน Product documentation
ลิ้งค์อื่นๆ ที่เกี่ยวข้อง

ข้อมูลเกี่ยวกับผลิตภัณฑ์สำหรับผู้บริโภค Consumer product support

ตำแหน่งงานว่าง Careers

Resources

^1.Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010 Jan 16;375(9710):201-9.
^2.Patel et al. Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions. Catheter Cardiovasc Interv 2013 June 1. In press doi: 10.1002/ccd.25034.)
^3.Iakovou I, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eluting stents. JAMA 2005;293:2126:2130.
^4. Kim, S, Kim Y, et al, Long-Term Outcomes of Intravascular Ultrasound-Guided Stenting in Coronary Bifurcation Lesions, Am J Cardiol 2010;106:612– 618.
^5. Mooney M, Teirstein P, Moses J, et al. Final results from the U.S. multi-center trial of the AngioSculpt Scoring Balloon Catheter for the treatment of complex coronary artery lesions. Am J Cardiol. 2006;98 (suppl 8):121M.
^6. Weisz G, Metzger DC, Liberman HA, O’Shaughnessy CD, Douglas JS, Turco MA, Mehran R, Gershony G, Leon MB, Moses JW. A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: Final Results of the AGILITY Trial. Catheterization and Cardiovascular Interventions 2013;82(3):352-359.